High materiality9/10
Definium Therapeutics price target raised to $73 from $48 at Piper Sandler
Why it may matterVerify against the original reporting
upside_potential
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Piper Sandler raises Definium Therapeutics' price target to $73 from $48; current price $42.93; upside ≈ 70%.
- Piper Sandler raises DFTX target to $73; price $42.93; upside ~70%
Key facts
- 01
Target: $73
- 02
Posted price: $42.93
- 03
Analyst firm: Piper Sandler
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.